Oliver Wyman March 24, 2022
Tobias Handschuh and Akshay Agarwal

From now on it’s focus, focus, focus

The pharmaceutical industry and the make-up of its lead players continues to evolve. The current trend is a clear drive towards more focused approach:

  • Focus on the prescription pharmaceutical business
  • Focus on innovative product
  • Focus on few targeted therapeutic areas

This paper examines the industry’s shifting landscape. We look at how key players have evolved their strategies over the past few years and offer predictions for what kind of deal activity to expect in 2022. Below is an excerpt of the report.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article